| Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer KA Preethi, SC Selvakumar, K Ross, S Jayaraman, D Tusubira, D Sekar Molecular Cancer 21 (1), 1-15, 2022 | 84 | 2022 |
| CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer SC Selvakumar, KA Preethi, K Ross, D Tusubira, MWA Khan, P Mani, ... Molecular Cancer 21 (1), 83, 2022 | 37 | 2022 |
| Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics SC Selvakumar, J Selvaraj, U Mony, VP Veeraraghavan, D Sekar, ... Oral oncology 125, 105713, 2022 | 11 | 2022 |
| MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways SC Selvakumar, KA Preethi, D Sekar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 188904, 2023 | 7 | 2023 |
| Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC) D Sekar, SC Selvakumar, KA Preethi Oral oncology 134, 106106, 2022 | 7 | 2022 |
| MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease SC Selvakumar, KA Preethi, D Tusubira, D Sekar Frontiers in Cellular Neuroscience 16, 995997, 2022 | 7 | 2022 |
| MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma SC Selvakumar, PK Auxzilia, Y Dinesh, M Senthilmurugan, D Sekar Oral Oncology, 105925, 2022 | 7 | 2022 |
| MicroRNAs and it’s targets in the treatment of salivary adenoid cystic carcinoma KA Preethi, SC Selvakumar, D Sekar Oral Oncology 133, 106053, 2022 | 3 | 2022 |
| Diagnostic and Therapeutic Application of Exosomal microRNAs Inducing Inflammation in Type 2 Diabetes Mellitus KA Preethi, SC Selvakumar, D Sekar Critical Reviews™ in Immunology 42 (1), 2022 | 3 | 2022 |
| Therapeutic aspect of microRNA inhibition in various types of hypertension and hypertensive complications KA Preethi, SC Selvakumar, K Ross, D Sekar Gene Reports, 101676, 2022 | 2 | 2022 |
| Expression profiling of signal transducer and activator of transcription3 in oral squamous cell carcinoma in south Indian population. P Thomas, SC Selvakumar, KA Preethi, D Sekar Minerva Dental and Oral Science, 2023 | 1 | 2023 |
| Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma P Thomas, KA Preethi, SC Selvakumar, P Ramani, D Sekar Journal of Oral and Maxillofacial Pathology 27 (2), 364-373, 2023 | 1 | 2023 |
| Non-coding RNAs influencing anti PD-1 immunotherapy in head and neck squamous cell carcinoma (HNSCC) SC Selvakumar, KA Preethi, D Sekar Oral oncology 134, 106092, 2022 | 1 | 2022 |
| Theragnostic implications of exosomes in preeclampsia SC Selvakumar, D Sekar, KA Preethi, S Jayaraman Hypertension Research 45 (1), 178-180, 2022 | 1 | 2022 |
| MicroRNA-34a-3p and its target tumor necrosis factor-α in the regulation of South Indian oral squamous cell carcinoma population. MS Varshan, SC Selvakumar, KA Preethi, K Murthykumar, D Sekar Minerva Dental and Oral Science, 2023 | | 2023 |
| Expression levels of microRNA-7110 in oral squamous cell carcinoma. M Neralla, A Preethi, SC Selvakumar, D Sekar Minerva Dental and Oral Science, 2023 | | 2023 |
| Gene expression analysis of microRNA-1285 in the South Indian oral squamous cell carcinoma population. M Neralla, SC Selvakumar, KA Preethi, D Sekar Minerva Dental and Oral Science, 2023 | | 2023 |
| Minerva Dental and Oral Science 2023 Jul 06 M NERALLA, S Hiranya, SC SELVAKUMAR, KA PREETHI, D SEKAR Minerva 20, 2023 | | 2023 |
| Prospective study: expression levels of microRNA-7-3p and its target STAT3 in head and neck cancer. FF Anees, KA Preethi, SC Selvakumar, K Murthykumar, D Ganapathy, ... Minerva Dental and Oral Science, 2023 | | 2023 |
| MicroRNA-510-3p and Its Gene Network in the Disease Regulation of Preeclampsia: An Insilico Approach SC Selvakumar, KA Preethi, K Ross, D Tusubira, D Sekar Journal of Biological Regulators and Homeostatic Agents 37 (4), 2291-2299, 2023 | | 2023 |
